Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Steve's Channelling Thread -- Ignore unavailable to you. Want to Upgrade?

To: hotlinktuna who wrote (23935)	8/14/2001 10:38:23 AM
From: Zeev Hed	Read Replies (2) \| Respond to of 30051

The increase in revenues is a little "misleading" it is mostly product sold which they were not doing last year. The beating is on the weakness on the service side, think that the market fears "another shoe", first the Pfizer loss and now possibly the Bayer loss. I still think it is not expensive here relative to others in the sector. But, it will have a lot of technical damage to repair, unless it closes above $46 today, which is what I was counting on. In the meanwhile, I took a small loss of $.30 on BRCD, I did not like it breaching $34 and sold on the bounce back. The market may not ait until tomorrow to peak, despite the current mildly up channels in the "Q". Zeev